Showing 1 - 6 results of 6 for search 'Tobias B Huber', query time: 0.01s Refine Results
  1. 1
    Clinical and Histopathological Determinants for Kidney Allograft Survival in the Eurotransplant Senior Program (ESP) at the Time of Allocation

    Clinical and Histopathological Determinants for Kidney Allograft Survival in the Eurotransplant Senior Program (ESP) at the Time of Allocation by Tom N. Langer, Tom N. Langer, Thorsten Wiech, Thorsten Wiech, Mercedes Noriega, Sergey Biniaminov, Tobias B. Huber, Tobias B. Huber, Lutz Fischer, Lutz Fischer, Florian Grahammer, Florian Grahammer, Florian Grahammer, Malte A. Kluger, Malte A. Kluger

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Microtubule Associated Protein 1b (MAP1B) Is a Marker of the Microtubular Cytoskeleton in Podocytes but Is Not Essential for the Function of the Kidney Filtration Barrier in Mice.

    Microtubule Associated Protein 1b (MAP1B) Is a Marker of the Microtubular Cytoskeleton in Podocytes but Is Not Essential for the Function of the Kidney Filtration Barrier in Mice. by Markus Gödel, Dunja Temerinac, Florian Grahammer, Björn Hartleben, Oliver Kretz, Beat M Riederer, Friedrich Propst, Stefan Kohl, Tobias B Huber

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy

    Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy by Felicitas E. Hengel, Michelle C.Z. Chong, Wing Yin Leung, Silke Dehde, Anne Mühlig, Matthias Janneck, Henry H.L. Wu, Tobias B. Huber, Arvind Ponnusamy, Nicola M. Tomas

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice

    Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice by Huiying Wang, Jonas Engesser, Robin Khatri, Darius P. Schaub, Hans-Joachim Paust, Zeba Sultana, Saskia-Larissa Jauch-Speer, Anett Peters, Anna Kaffke, Stefan Bonn, Tobias B. Huber, Hans-Willi Mittrücker, Christian F. Krebs, Ulf Panzer, Nariaki Asada

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The differential expression of MAGI2 in glomerulopathies and its application as a molecular discriminator of podocytopathies

    The differential expression of MAGI2 in glomerulopathies and its application as a molecular discriminator of podocytopathies by Florian Siegerist, Eleonora Hay, Elke Hammer, Anna Iervolino, Claudia Weber, Juan Saydou Dikou, Eleni Stamellou, Linus Butt, Thomas Benzing, Thorsten Wiech, Paul T. Brinkötter, Uwe Zimmerman, Giovambattista Capasso, Christos Chatziantoniou, Christos E. Chadjichristos, Tobias B. Huber, Uwe Völker, Maximilian Schindler, Nicole Endlich

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis

    Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis by Eva M Buhl, Sonja Djudjaj, Barbara M Klinkhammer, Katja Ermert, Victor G Puelles, Maja T Lindenmeyer, Clemens D Cohen, Chaoyong He, Erawan Borkham‐Kamphorst, Ralf Weiskirchen, Bernd Denecke, Panuwat Trairatphisan, Julio Saez‐Rodriguez, Tobias B Huber, Lorin E Olson, Jürgen Floege, Peter Boor

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: